Results 161 to 170 of about 3,360 (198)
Genes, 2022 Fengycin is a lipopeptide produced by Bacillus that has a strong inhibitory effect on filamentous fungi; however, its use is restricted due to poor production and low yield. Previous studies have shown that fengycin biosynthesis in B.
Muhammad Bilal +2 more
exaly +2 more sources
Functional analysis of fengycin synthetase FenD [PDF]
Biochimica Et Biophysica Acta Gene Regulatory Mechanisms, 2005 Fengycin is a cyclic lipopeptidic antibiotic produced nonribosomally by Bacillus subtilis. A fengycin synthetase mutant of B. subtilis F29-3 was generated with Tn917lux, which contains a transposon inserted in a 7716-bp gene, fenD. The mutation can be genetically complemented by transforming a plasmid carrying a wild-type fenD, confirming the ...
Chyi-Liang Chen +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Amino Acids Activated by Fengycin Synthetase FenE
Biochemical and Biophysical Research Communications, 2002Fengycin is a lipopeptidic antibiotic produced nonribosomally by Bacillus subtilis F29-3. Synthesis of this antibiotic requires five fengycin synthetases encoded by fenC, fenD, fenE, fenA, and fenB. In this study, we analyze the functions of the enzyme encoded by fenE, which contains two amino acid activation modules, FenE1 and FenE2.
Shih-Tung Liu
exaly +3 more sources
International Journal of Molecular Sciences, 2010 Fengycin, a lipopeptide biosurfactant, was produced by indigenous Bacillus subtilis F29-3 isolated from a potato farm. Although inhibiting the growth of filamentous fungi, the fengycin is ineffective against yeast and bacteria.
Wei-Chuan Chen +2 more
exaly +2 more sources
Termination of the structural confusion between plipastatin A1 and fengycin IX
Bioorganic and Medicinal Chemistry, 2012Plipastatin A1 and fengycin IX were experimentally proven to be identical compounds, while these had been considered as diastereomers due to the permutation of the enantiomeric pair of Tyr in most papers. The (1)H NMR spectrum changed to become quite similar to that of plipastatin A1, when the sample which provided resembled spectrum of fengycin IX was
Katsuhiro Konno +2 more
exaly +3 more sources
Selective fengycin production in a modified rotating discs bioreactor
Bioprocess and Biosystems Engineering, 2013Production of lipopeptides fengycin and surfactin in rotating discs bioreactor was studied. The effects of rotation velocity and the addition of agitators between the discs on volumetric oxygen transfer coefficient k L a were firstly studied in model media.
Krasimir Dimitrov +2 more
exaly +3 more sources
Biosynthesis and yield improvement strategies of fengycin
Archives of MicrobiologyFengycin is a cyclic lipopeptide antibiotic predominantly synthesized by Bacillus species. It exhibits remarkable antifungal, antitumor, and antiadhesion activities. It also possesses advantageous properties such as low toxicity, effective antibacterial activity, and biodegradability, making it a promising candidate for applications in biocontrol ...
Junfeng, Sun, Xiaohua, Qi, Chunmei, Du
openaire +2 more sources
Production of surfactin and fengycin by Bacillus subtilis in a bubbleless membrane bioreactor
Applied Microbiology and Biotechnology, 2010Surfactin and fengycin are lipopeptide biosurfactants produced by Bacillus subtilis. This work describes for the first time the use of bubbleless bioreactors for the production of these lipopeptides by B. subtilis ATCC 21332 with aeration by a hollow fiber membrane air-liquid contactor to prevent foam formation.
Coutte, François +6 more
openaire +5 more sources
Influence of promoters on the production of fengycin in Bacillus spp.
Research in Microbiology, 2016Fengycin is a promising antifungal lipopeptide from Bacillus spp. synthesized by non-ribosomal peptide synthetases (NRPS). In this work, fengycin production of a spontaneous fengycin overproducing strain, Bacillus subtilis BBG21, was first compared to those of B. subtilis BBG111 (a 168 derivative), B.
Yasseen, Y. +4 more
openaire +3 more sources
Fengycin C: a new isoform of fengycin lipopeptides produced by Bacillus subtilis EA-CB0015.
2021Using dual plate culture technique the cell free supernatant of B. subtilis EA-CB0015 produced inhibition percentages of 89 ± 1%.
Villegas-Escobar, Valeska +5 more
openaire +1 more source